Dolby Laboratories (NYSE:DLB – Get Free Report) updated its second quarter 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.190-1.340 for the period, compared to the consensus estimate of 1.350. The company issued revenue guidance of $355.0 million-$385.0 million, compared to the consensus revenue estimate of $387.2 million. Dolby Laboratories also updated its FY 2025 guidance to 3.990-4.140 EPS.
Dolby Laboratories Stock Performance
DLB traded down $0.02 on Wednesday, hitting $80.59. 405,447 shares of the company were exchanged, compared to its average volume of 450,844. The firm has a fifty day simple moving average of $79.18 and a two-hundred day simple moving average of $75.62. The stock has a market capitalization of $7.69 billion, a PE ratio of 29.74 and a beta of 0.98. Dolby Laboratories has a 12 month low of $66.35 and a 12 month high of $85.30.
Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its earnings results on Wednesday, January 29th. The electronics maker reported $0.84 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.23). Dolby Laboratories had a return on equity of 11.19% and a net margin of 20.56%. On average, equities analysts expect that Dolby Laboratories will post 2.92 earnings per share for the current year.
Dolby Laboratories Increases Dividend
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on DLB. Barrington Research restated an “outperform” rating and set a $100.00 price target on shares of Dolby Laboratories in a report on Monday. StockNews.com raised Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, December 4th. Finally, Rosenblatt Securities reaffirmed a “buy” rating and issued a $100.00 price target on shares of Dolby Laboratories in a research note on Thursday, January 23rd.
Check Out Our Latest Stock Report on Dolby Laboratories
Insider Buying and Selling
In related news, CAO Ryan Nicholson sold 10,500 shares of the business’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $80.18, for a total transaction of $841,890.00. Following the sale, the chief accounting officer now owns 24,364 shares of the company’s stock, valued at $1,953,505.52. The trade was a 30.12 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Mark Andrew Sherman sold 12,338 shares of the firm’s stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $78.08, for a total transaction of $963,351.04. Following the transaction, the executive vice president now directly owns 62,397 shares of the company’s stock, valued at $4,871,957.76. This represents a 16.51 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 135,917 shares of company stock valued at $10,877,739 over the last three months. Corporate insiders own 38.39% of the company’s stock.
About Dolby Laboratories
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Stories
- Five stocks we like better than Dolby Laboratories
- What Does Downgrade Mean in Investing?
- 3 Steel Stocks Soaring After Tariff Announcements
- What Are Dividend Champions? How to Invest in the Champions
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.